A 55-year-old male patient is presenting with severe chest pain, shortness of breath, and hypotension following a recent myocardial infarction. His ECG shows ST-segment elevations in the anterior leads. What is the most appropriate initial pharmacological intervention to improve his cardiac output?
In managing cardiogenic shock, especially post-myocardial infarction, inotropic support is often required to increase myocardial contractility. Dobutamine is a first-line inotropic agent for its ability to enhance cardiac output and reduce systemic vascular resistance. Other options like diuretics or beta-blockers may either exacerbate hypotension or are not indicated in acute settings like cardiogenic shock.
Ask Bash
Bash is our AI bot, trained to help you pass your exam. AI Generated Content may display inaccurate information, always double-check anything important.
What is dobutamine and how does it work in the heart?
Open an interactive chat with Bash
What signs indicate that a patient is experiencing cardiogenic shock?
Open an interactive chat with Bash
Why is furosemide not indicated in the acute setting of cardiogenic shock?
Open an interactive chat with Bash
BCEN CFRN
Resuscitation Principles
Your Score:
Report Issue
Bash, the Crucial Exams Chat Bot
AI Bot
Loading...
Loading...
Loading...
Nursing and Medical Assistants Package Join Premium for Full Access